Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: Effect on lung and systemic decorporation of plutonium

2007 ◽  
Vol 118 (1) ◽  
pp. 78-86 ◽  
Author(s):  
C. Gervelas ◽  
A.-L. Serandour ◽  
S. Geiger ◽  
G. Grillon ◽  
P. Fritsch ◽  
...  
Keyword(s):  
Dry Powder ◽  
Powder Formulation ◽  
Lung Delivery

Controlled release antibiotics for dry powder lung delivery

2009 ◽  
Vol 00 (00) ◽  
pp. 090805050810080-8 ◽  
Author(s):  
Handoko Adi ◽  
Paul Michael Young ◽  
Hak-Kim Chan ◽  
Rania Salama ◽  
Daniela Traini
Keyword(s):  
Controlled Release ◽  
Dry Powder ◽  
Lung Delivery

scholarly journals Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice

2018 ◽  
Vol 544 (1) ◽  
pp. 121-128 ◽  
Author(s):  
Ville Vartiainen ◽  
Janne Raula ◽  
Luis M. Bimbo ◽  
Jenni Viinamäki ◽  
Janne T. Backman ◽  
...  
Keyword(s):  
Lung Fibrosis ◽  
Dry Powder ◽  
Pulmonary Administration ◽  
Powder Formulation

Intratracheal Administration of Dry Powder Formulation in Mice

10.3791/61469 ◽  
2020 ◽  
Author(s):  
Yingshan Qiu ◽  
Qiuying Liao ◽  
Michael Y.T. Chow ◽  
Jenny K.W. Lam
Keyword(s):  
Dry Powder ◽  
Intratracheal Administration ◽  
Powder Formulation

scholarly journals MA17.09 5-Azacytidine Inhaled Dry Powder Formulation Profoundly Improves Pharmacokinetics and Efficacy for Lung Cancer Therapy

2019 ◽  
Vol 14 (10) ◽  
pp. S319-S320
Author(s):  
P. Kuehl ◽  
C. Tellez ◽  
M. Grimes ◽  
M. Burke ◽  
A. Badenoch ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
Dry Powder ◽  
Powder Formulation ◽  
Lung Cancer Therapy
Sign in / Sign up

Export Citation Format

Share Document